A
Alex Molassiotis
Researcher at Hong Kong Polytechnic University
Publications - 370
Citations - 15911
Alex Molassiotis is an academic researcher from Hong Kong Polytechnic University. The author has contributed to research in topics: Randomized controlled trial & Medicine. The author has an hindex of 62, co-authored 326 publications receiving 13481 citations. Previous affiliations of Alex Molassiotis include University of Liverpool & University of Malta.
Papers
More filters
Journal ArticleDOI
Use of complementary and alternative medicine in cancer patients: a European survey
Alex Molassiotis,Paz Fernadez-Ortega,Dorit Pud,Gulten Ozden,Julia A. Scott,Vassiliki Panteli,Anita Margulies,Maria Browall,Miriam Magri,Sarka Selvekerova,Elin Madsen,Ljiljana Milovics,Ingrid Bruyns,Gudbjorg Gudmundsdottir,Sandra Hummerston,A. M.-A. Ahmad,Nurgun Platin,Nora Kearney,Elisabeth Patiraki +18 more
TL;DR: It is imperative that health professionals explore the use of CAM with their cancer patients, educate them about potentially beneficial therapies in light of the limited available evidence of effectiveness, and work towards an integrated model of health-care provision.
Journal ArticleDOI
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
Fausto Roila,Jørn Herrstedt,Matti Aapro,Richard J. Gralla,Lawrence H. Einhorn,Enzo Ballatori,Emilio Bria,R. A. Clark-Snow,Birgitte T. Espersen,P. Feyer,Steven M. Grunberg,Paul J. Hesketh,Karin Jordan,Mark G. Kris,Ernesto Maranzano,Alex Molassiotis,Garry R. Morrow,Ian N. Olver,Bernardo Leon Rapoport,Cynthia N. Rittenberg,Mitsue Saito,Maurizio Tonato,David Warr +22 more
TL;DR: This guideline process was based on a literature review through 1 June 2009 using MEDLINE and other databases and believes that this is the most representative and evidence-based guideline process that has yet been performed.
Journal ArticleDOI
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients
Fausto Roila,Alex Molassiotis,Jørn Herrstedt,Matti Aapro,Richard J. Gralla,E. Bruera,Rebecca Clark-Snow,L. Lee Dupuis,Lawrence H. Einhorn,P. Feyer,Paul J. Hesketh,Karin Jordan,Ian N. Olver,Bernardo Leon Rapoport,Joseph A. Roscoe,Christina H Ruhlmann,Declan Walsh,David Warr,M. van der Wetering +18 more
TL;DR: The present research presents a novel and scalable approach that combines traditional and regenerative approaches to oncology that has real-time, real-world implications for individual patient care and quality of life.
Journal ArticleDOI
Unmet care needs of advanced cancer patients and their informal caregivers: a systematic review
TL;DR: Both advanced cancer patients and informal caregivers reported a wide range of context-bound unmet needs, and significant heterogeneity, including differences in study contexts, assessment methods, instruments for measurement, need classifications, and reporting methods, were identified across studies.
Journal ArticleDOI
Prevention of chemotherapy- and radiotherapy-induced emesis: Results of the 2004 Perugia International Antiemetic Consensus Conference
Fausto Roila,Matti Aapro,Enzo Ballatori,Sussanne Börjeson,Rebecca Clark-Snow,Albano Del Favero,Lawrence H. Einhorn,Petra Feyer,Richard J. Gralla,Steven M. Grunberg,Jørn Herrstedt,Paul J. Hesketh,Rolf Kaiser,Jim M. Koeller,Mark G. Kris,Ernesto Maranzano,Alex Molassiotis,Ian N. Olver,David Osoba,Bernardo Leon Rapoport,Cynthia N. Rittenberg,Maurizio Tonato,David Warr +22 more
TL;DR: Recommendations about antiemetic prophylaxis in patients receiving treatment with chemo- and radiotherapy have been updated by representatives of nine oncological organizations.